clarithromycin has been researched along with Bacteremia in 52 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 32 (61.54) | 18.2507 |
2000's | 12 (23.08) | 29.6817 |
2010's | 6 (11.54) | 24.3611 |
2020's | 2 (3.85) | 2.80 |
Authors | Studies |
---|---|
Karlowsky, JA; Zhanel, GG | 1 |
Agrawal, A; Ngwa, DN; Singh, SK | 1 |
Eguchi, M; Fukano, H; Hoshino, Y; Iguchi, M; Kanematsu, T; Kiyoi, H; Morioka, H; Oka, K; Sato, Y; Tetsuka, N; Yagi, T | 1 |
Mohamed Fuad, Z; Mohd Yusof, NH; Periasamy, P; Shaharir, SS; Sulaiman Sahari, N; Sulong, A; Zukiman, WZHW | 1 |
Cañas-Hernandez, F; de Miguel-Martinez, I; Lorenzo-Garde, L | 1 |
Altboum, Z; Bar-David, E; Glinert, I; Kobiler, D; Levy, H; Schlomovitz, J; Sittner, A; Weiss, S | 1 |
Chen, CH; Chen, YM; Lin, J; Lin, JS | 1 |
Al Azemi, M; Al Sweih, N; Bin Nakhi, HA; Joshi, RM; Nair, S | 1 |
Cajigas-Pezo, D; Lorenzo-Hernandez, A; Rentero-Martínez, Z; Vives-Rivero, GR | 1 |
Aoki, Y; Fukuoka, M; Hayashi, S; Nagasawa, K; Tominaga, M | 1 |
Bodasing, N; Kennedy, D | 1 |
Peetermans, WE; Van Kerkhoven, D; Verbist, L; Verhaegen, J | 1 |
Arnold, P; Dietrich, U; Guscetti, F; Pfyffer, GE; Spiess, B | 1 |
Freudenberger, R; Mahal, M; Mateo-Bibeau, R; Naik, S; Shinnar, M | 1 |
Adelman, MH; Chiou, CC; Klugman, KP; Lavin, B; Paladino, JA; Patel, M; Schentag, JJ; Wilton, GJ; Yu, VL | 1 |
Chin, DP; Hopewell, PC | 1 |
Singh, N; Yu, VL | 1 |
Delia, S; Iona, E; Mascellino, MT; Mastroianni, CM; Ponzo, R | 1 |
Danner, SA; van der Meer, JT | 1 |
Musher, DM | 1 |
Goodman, NL; McCraney, SA; Rapp, RP; Shaddick, DJ | 1 |
Benson, CA; Chaisson, RE; Craft, JC; Dube, MP; Elkin, S; Heifets, LB; Korvick, JA; Sattler, FR; Smith, T | 1 |
Goldberger, M; Masur, H | 1 |
Lonks, JR; Medeiros, AA | 1 |
Deschênes, J; Miller, M; Phillips, P; Shafran, SD; Toma, E | 1 |
Behling, CA; Haubrich, RH; Havlir, DV; McCutchan, JA; Torriani, FJ | 1 |
Fanning, MM; Fong, IW; Gill, MJ; Lalonde, RG; Phillips, P; Rachlis, AR; Salit, I; Shafran, SD; Singer, J; Tsoukas, CM; Walmsley, SL; Zarowny, DP | 1 |
Bradley, JS; Hindler, J; Reid, R | 1 |
Beuscart, C; Brel, F; Dautzenberg, B; Doco-Lecompte, T; Grosset, J; May, T; Perronne, C; Saint-Marc, T; Vincent, V | 1 |
Brel, F; Lecompte, T; May, T; Picardeau, M; Varnerot, A; Vincent, V | 1 |
Bartok, AE; Bozzette, SA; Dezfuli, MG; Dubé, MP; Havlir, DV; Kemper, CA; Leedom, JM; McCutchan, JA; Sattler, FR; See, D; Tilles, JG; Torriani, FJ | 1 |
Aoki, FY; Deschênes, J; Duperval, R; Lemieux, C; Miller, M; Phillips, P; Schlech, WF; Shafran, SD; Singer, J; Toma, E; Turgeon, F; Zarowny, DP | 1 |
Burman, WJ; Cohn, DL; Reves, RR; Rietmeijer, CA | 1 |
Burman, WJ; Cohn, DL; Maslow, J; Reves, RR; Rietmeijer, CA; Stone, BL | 1 |
Barzilai, A; Blank-Porat, D; Keller, N; Levi, I; Rubinovich, B; Rubinstein, E | 1 |
Craft, JC; Grosset, JH; Heifets, LB; Notario, GF | 1 |
Shafran, SD | 1 |
Evans, TG; Heifets, L; Huycke, M; Kauffman, C; Rimland, D; Ward, TT | 1 |
Cadwgan, AM; Laing, RB; MacKenzie, AR | 1 |
Chomyc, S; Davison, E; Fong, IW; Gill, MJ; Lalonde, RG; Phillips, P; Rachlis, AR; Salit, I; Shafran, SD; Singer, J; Talbot, JA; Walmsley, SL | 1 |
Dubé, MP; Havlir, DV; Kemper, CA; Leedom, JM; McCutchan, JA; Sattler, FR; See, D; Tilles, JG; Torriani, FJ | 1 |
Burguière, AM; Eliaszewicz, M; Flahault, A; Fournier, S; Treilhou, MP; Vincent, V | 1 |
Drusano, G; Hafner, R; Inderlied, CB; Muth, K; Peterson, DM; Standiford, HC; Wright, DJ | 1 |
Guenounou, M; Matsiota-Bernard, P; Onody, C; Zinzendorf, N | 1 |
Khorasheh, S; Lemieux, C; Raboud, JM; Salit, I; Shafran, SD; Singer, J; Thorne, A; Tsoukas, CM; Wu, AW | 1 |
Cohen, MS; Gilligan, P; Kelley, MA; Weber, DJ | 1 |
Benson, C | 1 |
Prescott, LM | 1 |
Ali, SA; Bilgrami, S; Bona, RD; Clive, J; Dorsky, D; Edwards, RL; Feingold, JM; Naqvi, B; Tutschka, PJ | 1 |
Buezas, V; Mellado, F; Montero, A; Ramón Maestre, J; Sánchez, P | 1 |
Chen, HY; Maskell, JP; Powell, M | 1 |
Caccamo, F; de Lalla, F; Marone, P; Maserati, R; Nicolin, R; Rigoli, R; Scarpellini, P | 1 |
1 review(s) available for clarithromycin and Bacteremia
Article | Year |
---|---|
New macrolide antibiotics: usefulness in infections caused by mycobacteria other than Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Azithromycin; Bacteremia; Clarithromycin; Drug Synergism; Erythromycin; Humans; Microbial Sensitivity Tests; Multicenter Studies as Topic; Mycobacterium Infections, Nontuberculous; Randomized Controlled Trials as Topic | 1994 |
13 trial(s) available for clarithromycin and Bacteremia
Article | Year |
---|---|
Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team.
Topics: Adult; AIDS-Related Opportunistic Infections; Bacteremia; Clarithromycin; Colony Count, Microbial; Double-Blind Method; Drug Administration Schedule; Drug Resistance, Microbial; Female; Humans; Male; Mycobacterium avium-intracellulare Infection; Prospective Studies; Survival Analysis | 1994 |
Uveitis and pseudojaundice during a regimen of clarithromycin, rifabutin, and ethambutol. MAC Study Group of the Canadian HIV Trials Network.
Topics: AIDS-Related Opportunistic Infections; Bacteremia; Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Jaundice; Mycobacterium avium-intracellulare Infection; Prospective Studies; Rifabutin; Uveitis | 1994 |
A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Bacteremia; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin; Rifampin; Survival Analysis; Treatment Outcome; Uveitis | 1996 |
Comparison of combination therapy regimens for treatment of human immunodeficiency virus-infected patients with disseminated bacteremia due to Mycobacterium avium. ANRS Trial 033 Curavium Group. Agence Nationale de Recherche sur le Sida.
Topics: Adult; AIDS-Related Opportunistic Infections; Bacteremia; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Mycobacterium avium-intracellulare Infection; Prospective Studies; Recurrence; Rifabutin | 1997 |
A randomized evaluation of ethambutol for prevention of relapse and drug resistance during treatment of Mycobacterium avium complex bacteremia with clarithromycin-based combination therapy. California Collaborative Treatment Group.
Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; Bacteremia; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Mycobacterium avium-intracellulare Infection; Prospective Studies; Recurrence | 1997 |
Determinants of rifabutin-associated uveitis in patients treated with rifabutin, clarithromycin, and ethambutol for Mycobacterium avium complex bacteremia: a multivariate analysis. Canadian HIV Trials Network Protocol 010 Study Group.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Bacteremia; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Mycobacterium avium-intracellulare Infection; Rifabutin; Risk Factors; Uveitis | 1998 |
Clarithromycin resistance and susceptibility patterns of Mycobacterium avium strains isolated during prophylaxis for disseminated infection in patients with AIDS.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Bacteremia; Clarithromycin; Double-Blind Method; Drug Resistance, Microbial; Female; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies | 1998 |
Randomized, open-label trial of azithromycin plus ethambutol vs. clarithromycin plus ethambutol as therapy for Mycobacterium avium complex bacteremia in patients with human immunodeficiency virus infection. Veterans Affairs HIV Research Consortium.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Azithromycin; Bacteremia; Clarithromycin; Drug Therapy, Combination; Ethambutol; HIV-1; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Time Factors; Treatment Outcome | 1998 |
Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin? Canadian HIV Trials Network Protocol 010 Study Group.
Topics: AIDS-Related Opportunistic Infections; Bacteremia; Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Predictive Value of Tests; Rifabutin | 1998 |
Successful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS. California Collaborative Treatment Group.
Topics: AIDS-Related Opportunistic Infections; Bacteremia; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin | 1999 |
Effect of adding clofazimine to combined clarithromycin-ethambutol therapy for Mycobacterium avium complex septicemia in AIDS patients.
Topics: Aged; AIDS-Related Opportunistic Infections; Anti-Inflammatory Agents, Non-Steroidal; Bacteremia; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Survival Analysis | 1999 |
Comparison of clarithromycin-sensitive and clarithromycin-resistant Mycobacterium avium strains isolated from AIDS patients during therapy regimens including clarithromycin.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Bacteremia; Cell Line; Clarithromycin; DNA, Bacterial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Monocytes; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Nucleic Acid Hybridization; Random Amplified Polymorphic DNA Technique; Recurrence; Tumor Necrosis Factor-alpha | 2000 |
Symptomatic and health status outcomes in the Canadian randomized MAC treatment trial (CTN010). Canadian HIV Trials Network Protocol 010 Study Group.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Bacteremia; Canada; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Health Status; Humans; Mycobacterium avium-intracellulare Infection; Outcome and Process Assessment, Health Care; Rifabutin; Rifampin; Treatment Outcome | 2000 |
38 other study(ies) available for clarithromycin and Bacteremia
Article | Year |
---|---|
In vitro activity of Iclaprim against respiratory and bacteremic isolates of Streptococcus pneumoniae.
Topics: Bacteremia; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Pyrimidines; Respiratory System; Streptococcus pneumoniae; Trimethoprim, Sulfamethoxazole Drug Combination | 2009 |
C-Reactive Protein-Based Strategy to Reduce Antibiotic Dosing for the Treatment of Pneumococcal Infection.
Topics: Amino Acid Substitution; Animals; Anti-Bacterial Agents; Bacteremia; C-Reactive Protein; Clarithromycin; Drug Evaluation, Preclinical; Drug Therapy, Combination; Immunity, Innate; Male; Mice; Mice, Inbred C57BL; Mutagenesis, Site-Directed; Mutation, Missense; Pneumococcal Infections; Recombinant Proteins | 2020 |
Bursitis, Bacteremia, and Disseminated Infection of Mycobacteroides (Mycobacterium) abscessus subsp. massiliense.
Topics: Anti-Bacterial Agents; Bacteremia; Bursitis; Clarithromycin; Female; Humans; Microbial Sensitivity Tests; Middle Aged; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous | 2021 |
Non-tuberculous mycobacterium bacteraemia in a pregnant systemic lupus erythematosus (SLE) patient: a case review and pooled case analysis.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Clarithromycin; Female; Humans; Lupus Erythematosus, Systemic; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Pregnancy; Treatment Outcome | 2018 |
[Bacteriemia due to Mycobacterium canariasense in an oncohematological patient with a long-term central device].
Topics: Aged; Bacteremia; Bacterial Typing Techniques; Catheter-Related Infections; Catheterization, Central Venous; Ciprofloxacin; Clarithromycin; Humans; Lymphoma, Non-Hodgkin; Male; Mycobacterium; Mycobacterium Infections | 2014 |
Efficacy of Single and Combined Antibiotic Treatments of Anthrax in Rabbits.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Bacteremia; Ciprofloxacin; Clarithromycin; Disease Models, Animal; Doxycycline; Drug Combinations; Drug Synergism; Humans; Imipenem; Linezolid; Male; Microbial Sensitivity Tests; Rabbits; Respiratory Tract Infections; Rifampin; Spores, Bacterial; Survival Analysis; Vancomycin | 2015 |
Mycobacterium abscessus complex bacteremia due to prostatitis after prostate biopsy.
Topics: Anti-Bacterial Agents; Bacteremia; Biopsy; Clarithromycin; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Prostatitis | 2016 |
Streptobacillus moniliformis bacteremia in a child: case report.
Topics: Anti-Bacterial Agents; Bacteremia; Cefotaxime; Clarithromycin; Female; Fusobacterium Infections; Humans; Infant; Streptobacillus | 2010 |
[Swelling of right knee in an immunologically compromised patient].
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Arthritis, Infectious; Bacteremia; Candidiasis, Oral; Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Immunocompromised Host; Isoniazid; Knee Joint; Male; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Radiography; Rifampin; Tuberculosis, Osteoarticular | 2012 |
[A case of bacteremic group A streptococcus infection with organ dysfunction following a minor skin abrasion].
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Bacteremia; Clarithromycin; Humans; Male; Multiple Organ Failure; Penicillins; Shock, Septic; Skin; Streptococcal Infections; Streptococcus pyogenes | 2002 |
Moraxella catarrhalis bacteraemia associated with Mycoplasma pneumoniae infection and pneumonia.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; Breast Neoplasms; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gram-Negative Bacterial Infections; Humans; Moraxella catarrhalis; Mycoplasma pneumoniae; Pneumonia, Mycoplasma | 2002 |
Breakthrough pneumococcal bacteraemia in patients treated with clarithromycin or oral beta-lactams.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Bacteremia; beta-Lactam Resistance; beta-Lactams; Clarithromycin; Drug Resistance, Bacterial; Female; Humans; Male; Middle Aged; Pneumococcal Infections; Retrospective Studies; Treatment Failure | 2003 |
Ocular manifestation of disseminated Mycobacterium simiae infection in a cat.
Topics: Animals; Anti-Infective Agents; Antitubercular Agents; Bacteremia; Cat Diseases; Cats; Clarithromycin; Diagnosis, Differential; Diagnostic Techniques, Ophthalmological; Drug Therapy, Combination; Enrofloxacin; Fluoroquinolones; Male; Mycobacterium; Mycobacterium Infections; Quinolones; Radiography; Rifampin; Tuberculosis, Ocular | 2003 |
Successful treatment of Nocardia nova bacteremia and multilobar pneumonia with clarithromycin in a heart transplant patient.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Clarithromycin; Heart Transplantation; Humans; Lung Diseases; Male; Nocardia Infections; Pneumonia; Postoperative Complications | 2007 |
Streptococcus pneumoniae bacteraemia: pharmacodynamic correlations with outcome and macrolide resistance--a controlled study.
Topics: Anti-Bacterial Agents; Area Under Curve; Azithromycin; Bacteremia; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Humans; Macrolides; Microbial Sensitivity Tests; Pneumococcal Infections; Retrospective Studies; Streptococcus pneumoniae; Treatment Failure | 2007 |
How to treat bacteraemic Mycobacterium avium complex disease.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Bacteremia; Clarithromycin; Drug Therapy, Combination; Humans; Mycobacterium avium-intracellulare Infection; Randomized Controlled Trials as Topic; Rifabutin; Survival Rate; Treatment Outcome | 1995 |
Clarithromycin therapy for Mycobacterium avium complex bacteremia.
Topics: AIDS-Related Opportunistic Infections; Bacteremia; Clarithromycin; Drug Administration Schedule; Humans; Mycobacterium avium-intracellulare Infection; Treatment Outcome | 1995 |
Infections due to Rhodococcus equi in three HIV-infected patients: microbiological findings and antibiotic susceptibility.
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Azithromycin; Bacteremia; Bronchoalveolar Lavage Fluid; Clarithromycin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; HIV Infections; Humans; Imipenem; Male; Pleurisy; Pneumonia, Bacterial; Rhodococcus equi; Rifampin; Sputum; Teicoplanin; Vancomycin | 1994 |
Clarithromycin therapy for Mycobacterium avium complex bacteremia.
Topics: AIDS-Related Opportunistic Infections; Bacteremia; Clarithromycin; Drug Administration Schedule; Humans; Mycobacterium avium-intracellulare Infection; Treatment Outcome | 1995 |
Clarithromycin therapy for Mycobacterium avium complex bacteremia.
Topics: AIDS-Related Opportunistic Infections; Bacteremia; Clarithromycin; Drug Administration Schedule; Humans; Mycobacterium avium-intracellulare Infection; Treatment Outcome | 1995 |
Clarithromycin therapy for Mycobacterium avium complex disease in patients with AIDS: potential and problems.
Topics: AIDS-Related Opportunistic Infections; Bacteremia; Clarithromycin; Humans; Mycobacterium avium-intracellulare Infection | 1994 |
High rate of erythromycin and clarithromycin resistance among Streptococcus pneumoniae isolates from blood cultures from Providence, R.I.
Topics: Adult; Aged; Bacteremia; Child; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumococcal Infections; Rhode Island; Streptococcus pneumoniae | 1993 |
Disseminated Mycobacterium avium complex: correlation between blood and tissue burden.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Bacterial Agents; Autopsy; Bacteremia; Clarithromycin; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies; Tissue Distribution | 1996 |
Pneumococcal meningitis during therapy of otitis media with clarithromycin.
Topics: Acute Disease; Anti-Bacterial Agents; Anti-Inflammatory Agents; Bacteremia; Cerebrospinal Fluid; Clarithromycin; Dexamethasone; Drug Therapy, Combination; Female; Humans; Infant; Infusions, Intravenous; Meningitis, Pneumococcal; Meropenem; Microbial Sensitivity Tests; Otitis Media; Streptococcus pneumoniae; Thienamycins | 1995 |
Use of different molecular typing techniques for bacteriological follow-up in a clinical trial with AIDS patients with Mycobacterium avium bacteremia.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; Clarithromycin; Clinical Trials as Topic; Cluster Analysis; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Follow-Up Studies; France; Humans; Multicenter Studies as Topic; Mycobacterium avium; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Recurrence; Serotyping; Treatment Failure; Tuberculosis | 1997 |
A retrospective comparison of clarithromycin versus rifampin in combination treatment for disseminated Mycobacterium avium complex disease in AIDS: clarithromycin decreases transfusion requirements.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotics, Antitubercular; Bacteremia; Blood Transfusion; Clarithromycin; Colorado; Community Health Centers; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin; Survival Rate; Treatment Outcome | 1997 |
Long-term outcomes of treatment of Mycobacterium avium complex bacteremia using a clarithromycin-containing regimen.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Bacteremia; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Time Factors; Treatment Outcome | 1998 |
Successful treatment of disseminated Mycobacterium simiae infection in AIDS patients.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Bacteremia; Ciprofloxacin; Clarithromycin; Disease-Free Survival; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Prognosis; Retrospective Studies; Treatment Outcome | 1998 |
Clarithromycin prophylaxis for disseminated Mycobacterium avium complex infection--efficacy and acquired resistance.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Bacteremia; Clarithromycin; Drug Resistance, Microbial; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Survival Rate | 1998 |
Neisseria meningitidis W135 pneumonia with sepicaemia in a nonogenarian.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Clarithromycin; Female; Humans; Meningococcal Infections; Neisseria meningitidis; Pneumonia, Bacterial; Serotyping; Sinusitis | 1998 |
Correlation of quantitative bone marrow and blood cultures in AIDS patients with disseminated Mycobacterium avium complex infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Bacteremia; Biopsy; Blood; Bone Marrow; Clarithromycin; Colony Count, Microbial; Culture Media; Ethambutol; Female; HIV-1; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; RNA, Viral | 1999 |
Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin.
Topics: Aged; Anti-Bacterial Agents; Azithromycin; Bacteremia; Child, Preschool; Clarithromycin; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Pneumococcal Infections; Streptococcus pneumoniae; Treatment Failure | 2000 |
Advances in the diagnosis and treatment of Mycobacterium avium complex (MAC) disease.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Azithromycin; Bacteremia; Bone Marrow; Clarithromycin; Drug Therapy, Combination; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin | 1994 |
Macrolides, azalides, and streptogrammins.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteremia; Bacterial Infections; Clarithromycin; Clofazimine; Cryptosporidiosis; Drug Therapy, Combination; Duodenal Ulcer; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium avium-intracellulare Infection; Pneumonia; Smoking; Virginiamycin | 1996 |
Efficacy of clarithromycin in preventing viridans streptococcal bacteremia following autologous stem cell transplantation.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacteremia; Child; Child, Preschool; Clarithromycin; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Middle Aged; Retrospective Studies; Risk Factors; Streptococcal Infections; Streptococcus; Treatment Outcome | 2001 |
[Bacteremia caused by Campylobacter jejuni in a 22 year old male with autoimmune haemolytic anaemia].
Topics: Adult; Anemia, Hemolytic, Autoimmune; Bacteremia; Campylobacter Infections; Campylobacter jejuni; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Gastroenteritis; Gentamicins; Humans; Immunocompromised Host; Jaundice; Male; Splenectomy; Splenomegaly | 2001 |
Protective efficacy of clarithromycin and its 14-hydroxy metabolite against Haemophilus influenzae in a murine septicaemia model.
Topics: Animals; Bacteremia; Clarithromycin; Disease Models, Animal; Drug Synergism; Erythromycin; Female; Haemophilus Infections; Haemophilus influenzae; Mice; Mice, Inbred BALB C | 1992 |
Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amikacin; Bacteremia; Cause of Death; Ciprofloxacin; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Erythromycin; Female; Humans; Male; Mycobacterium avium-intracellulare Infection; Pilot Projects | 1992 |